H1B Salary Data

Home › Employers › OrthoPediatrics Corp.

OrthoPediatrics Corp.: H-1B salaries and sponsorship

OrthoPediatrics Corp. filed 4 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 4. Median offered salary: $64,143.

Applications (LCAs)4
Certified4
Employer addressWarsaw, IN
H-1B dependent employerNo
Median offered salary$64,143
Middle half of salaries$60,000–$68,840
10th–90th percentile$60,000–$69,836

Does OrthoPediatrics Corp. sponsor H-1B visas?

OrthoPediatrics Corp. filed 4 labor condition applications in fiscal years 2023–2026, the latest submitted on Sep 26, 2024. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Development Engineer3$68,286
Regulatory Affairs Specialist1$60,000

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20243$60,000
FY20251$70,500

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Development Engineer$70,500
Level I
Kansas City, MOSep 26, 2024Oct 4, 2024Certified
Development Engineer$68,286
Level I
Warsaw, INMay 6, 2024Oct 1, 2024Certified
Regulatory Affairs Specialist$60,000
Level II
Warsaw, INApr 22, 2024Oct 1, 2024Certified
Development Engineer$60,000
Level II
Warsaw, INApr 22, 2024Oct 1, 2024Certified, then withdrawn

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).